Review Article

Manipulating Protein Acetylation in Breast Cancer: A Promising Approach in Combination with Hormonal Therapies?

Table 3

HDACs and estrogen signaling.

HDACEffect on estrogen signalingReferences

HDAC1Recruited to the silenced ERα promoter[80]
Present on ER-target gene promoter region[81]
Knockdown reduces ERα levels[82]
Directly interact with ERα-suppresses ERα activity in 293T cells[83]

HDAC2Present on ER-target gene promoter region[84]
Knockdown reduces ERα levels[82]

HDAC3Present on ER-target gene promoter region[81]

HDAC4Present on ER-target gene promoter region[85]
Binds the N-terminal A/B domain of ERα[86]

HDAC5Repress ERα promoter via MEF2[87]
Directly interacts with ERα-Represses ERα activity
KO associated with upregulation of ERα signaling

HDAC6Knockdown reduces ERα levels[82]
Bind the AF2-domain of ERα[88]
Regulates ERα degradation via hsp90 acetylation[89]

HDAC7Present on the pS2 gene promoter region[84]
Represses ERα activity-Required for E2-dependent repression[90]

HDAC9Repress ERα promoter via MEF2[87]
Directly interacts with ERα-Represses ERα activity
KO associated with upregulation of ERα signaling

SIRT1Deacetylates ERαin vitro
Knockdown reduces ERα levels[91]